PinnyPeptide

Dihexa vs P21 (P021)

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Dihexa

Cognitive

Hepatocyte growth factor mimetic — claimed to be 7 orders of magnitude more potent than BDNF.

Peptide B

P21 (P021)

Cognitive

Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research.

Typical vial

30 mg

Typical dose

8,000-45,000 (oral) mcg

Half-life

~3-4 hours (oral)

FDA status

Not FDA approved. The related HGF-positive modulator fosgoni…

Typical vial

5 mg

Typical dose

Per kg dosing mcg

Half-life

Variable; designed for sustained activity

FDA status

Not FDA approved.

Dihexa effects

  • Claimed promotion of dendritic spine formation
  • HGF / c-Met signaling enhancement
  • Procognitive effects in rodent models
  • Orally bioavailable (rare for peptides)
  • Anecdotal cognitive enhancement in human users

P21 (P021) effects

  • Promotes adult hippocampal neurogenesis
  • Increases dendritic spine density
  • Reduces tau hyperphosphorylation (anti-tauopathy)
  • Improves learning and memory in Alzheimer's mouse models
  • Crosses the blood-brain barrier after peripheral administration

Dihexa side effects

  • Essentially uncharacterized in humans
  • Headache (commonly reported in self-experimentation)
  • Increased emotionality / mood changes (subjective reports)
  • Theoretical: pro-oncogenic concerns via HGF / c-Met activation
  • Insomnia with late-day dosing

P21 (P021) side effects

  • Essentially uncharacterized in humans
  • Theoretical: off-target effects on CNTF / leptin receptor pathways
  • Possible effects on appetite and metabolism (CNTF-family signaling)
  • Injection-site reactions

Dihexa dosing ranges

Cognitive research (oral / sublingual)

8-45 mg · Once daily · 30 days per cycle

P21 (P021) dosing ranges

Neurogenesis research (preclinical)

40-200 mcg/kg · Daily or alternate-day SubQ · Per research protocol

Full Dihexa guide → Full P21 (P021) guide →

Dihexa vs P21 (P021) — common questions

What is the difference between Dihexa and P21 (P021)?

Dihexa: Hepatocyte growth factor mimetic — claimed to be 7 orders of magnitude more potent than BDNF. Typical dose 8,000-45,000 (oral) mcg. P21 (P021): Neurogenic, anti-tau peptide derived from ciliary neurotrophic factor — Alzheimer's research. Typical dose Per kg dosing mcg. Both fall under the Cognitive category.

Can you stack Dihexa and P21 (P021)?

Stacking Dihexa with P21 (P021) is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Dihexa or P21 (P021)?

Dihexa is typically dosed: Once daily for Cognitive research (oral / sublingual). P21 (P021) is typically dosed: Daily or alternate-day SubQ for Neurogenesis research (preclinical).

Are Dihexa and P21 (P021) FDA approved?

Dihexa: Not FDA approved. The related HGF-positive modulator fosgonimeton (ATH-1017) is in clinical trials for Alzheimer's. P21 (P021): Not FDA approved.

Related peptide comparisons

adamax vs dihexacolivelin vs dihexadihexa vs dnsp-11dihexa vs pe22-28dihexa vs pinealonadamax vs p21

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free